Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

March 3, 2022

Study Completion Date

March 3, 2022

Conditions
Refractory Glaucoma
Interventions
DEVICE

XEN Glaucoma Stent

Data are collected from patients who are implanted with XEN via the specific urgent medical needs for named patient use regulatory pathway in Hainan

Trial Locations (1)

571434

Boao Super Hospital /ID# 233669, Qionghai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT04303897 - Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma | Biotech Hunter | Biotech Hunter